欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0497/001
药品名称Bendamustine Accord 2.5 mg/ml Powder for concentrate for solution for infusion
活性成分
    • Bendamustine 2.5 mg
剂型Powder for concentrate for solution for infusion/injection
上市许可持有人Accord Healthcare B.V Winthontlaan 200 3526 KV Utrecht NL
参考成员国 - 产品名称Austria (AT)
Bendamustin Accord 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
互认成员国 - 产品名称
    • Latvia (LV)
      Bendamustine Accord 2,5 mg/ml pulveris infūziju šķīduma koncentrāta pagatavošanai
    • Portugal (PT)
    • Sweden (SE)
    • Czechia (CZ)
      Bendamustine Accord 2,5 mg/ml prášek pro koncentrát pro infuzní roztok
    • Romania (RO)
      Bendamustina Accord 2,5 mg/ml pulbere pentru concentrat pentru solutie perfuzabila
    • Slovenia (SI)
    • United Kingdom (GB)
    • Cyprus (CY)
      BENDAMUSTINE ACCORD
    • Denmark (DK)
    • Germany (DE)
      Bendamustine Accord 2,5 mg/ml Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
    • Iceland (IS)
      Bendamustine Accord 2,5 mg/ml Stofn fyrir innrennslisþykkni, lausn
    • Belgium (BE)
    • Ireland (IE)
    • France (FR)
    • Spain (ES)
    • Netherlands (NL)
    • Norway (NO)
      Bendamustine Accord
    • United Kingdom (Northern Ireland) (XI)
    • Finland (FI)
    • Estonia (EE)
      Bendamustine Accord
    • Poland (PL)
      Bendamustine Accord
    • Greece (GR)
      BENDAMUSTINE/ACCORD
    • Hungary (HU)
      BENDAMUSTINE ACCORD 2,5 mg/ml por oldatos infúzióhoz való koncentrátumhoz
    • Italy (IT)
    • Malta (MT)
    • Lithuania (LT)
      Bendamustine Accord 2,5 mg/ml milteliai infuzinio tirpalo koncentratui
许可日期2014/07/17
最近更新日期2024/12/30
药物ATC编码
    • L01AA09 bendamustine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase